51 results
8-K
EX-5.1
IMCR
Immunocore Holdings plc
5 Apr 24
Other Events
4:35pm
of the Company in all respects.
ASSUMPTIONS
In giving the opinions in this letter, we have assumed (without making enquiry or investigation) that:
all … after the date of this letter which would alter the opinion given in this letter.
We have not been responsible for investigation or verification
S-8
EX-5.1
IMCR
Immunocore Holdings plc
20 Mar 24
Registration of securities for employees
8:55pm
(without making enquiry or investigation) that:
all signatures, stamps and seals on all documents are genuine. All original documents are complete … given in this letter.
We have not been responsible for investigation or verification of statements of fact (including statements as to foreign law
S-3ASR
EX-5.2
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
capital.
ASSUMPTIONS
In giving the opinions in this letter, we have assumed (without making enquiry or investigation) that:
all signatures, stamps … the true meaning or import of the terms of the Sales Agreement under New York law, and we have made no investigation of such meaning or import
S-3ASR
EX-5.1
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
in this letter, we have assumed (without making enquiry or investigation) that:
all signatures, stamps and seals on all documents are genuine. All original … and the Warrant Agreements under New York law, and we have made no investigation of such meaning or import. Therefore, our review of the Indenture
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
addressed and the FDA has notified the company that investigation may proceed and then only under terms authorized by the FDA. This could cause … investigation plan, or PIP, agreed with the EMA’s Pediatric Committee, or PDCO. The PIP sets out the timing and measures proposed to generate data
10-K
EX-10.14
tr3rxtn
28 Feb 24
Annual report
7:33am
8-K
EX-4.1
v29esjuqo0eruph0f
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
S-8
EX-5.1
4ncw0n7ni5
6 Apr 23
Registration of securities for employees
4:24pm
6-K
EX-99.4
5hjcnyx9d
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-5.2
nej48avewm30m 5ba
30 Sep 22
Current report (foreign)
4:24pm
6-K
EX-5.1
eou982
30 Sep 22
Current report (foreign)
4:24pm
6-K
EX-5.1
bn8qha7wad
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
6-K
EX-1.1
5ot1kx87glcsnxqu4bkb
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
6-K
EX-99.1
njuuryhzhwqc45
20 Jul 22
Securities Purchase Agreement
4:06pm
S-8
EX-5.1
p1r413a
17 May 22
Registration of securities for employees
7:01am
F-3ASR
EX-4.4
cqkxutoup 5lar0f
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
EX-5.1
3ra6d dqv5lafoeb3
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
S-8
EX-5.1
iavk0kgfm
12 Apr 21
Registration of securities for employees
4:02pm
S-8
fu99dqy9ow
12 Apr 21
Registration of securities for employees
4:02pm